ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #1,020Top JournalHybrid

Cancer

Abbreviation (ISO):CANCER-AM CANCER SOC
•
Identifier (ISSN):0008-543X(Print)/1097-0142(Online)
•
Publisher:John Wiley and Sons Inc.
Clarivate IF (2026)
5.6↑ +0.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Cancer

WoS Q1
35796.5420186.120195.7420206.8620216.9220226.220236.120245.120255.62026
Annual Impact Factor Metric
Current (2026):5.6
Scopus SJR & RankScopus Q1
2.427
#1,020

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
359

359 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate1.6%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
435articles/year
40.3% Gold OA•92.35% Original Research

Aims & Scope

The CANCER site is a full-text, electronic implementation of CANCER, an Interdisciplinary International Journal of the American Cancer Society, and CANCER CYTOPATHOLOGY, a Journal of the American Cancer Society. CANCER publishes interdisciplinary oncologic information according to, but not limited to, the following disease sites and disciplines: blood/bone marrow; breast disease; endocrine disorders; epidemiology; gastrointestinal tract; genitourinary disease; gynecologic oncology; head and neck disease; hepatobiliary tract; integrated medicine; lung disease; medical oncology; neuro-oncology; pathology radiation oncology; translational research

Topics Covered (Recognized by AI)
MedicineBiologyInternal MedicineGeneticsPathologyOncology & Cancer ResearchSurgeryChemistryImmunologyOncologyRadiologyBiochemistry
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q1
Rank74/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q1
Rank69/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF5.6
Articles / Year395
Total Citations188
2025
IF5.1
Articles / Year567
Total Citations1,807
2024
IF6.1
Articles / Year549
Total Citations4,751
2023
IF6.2
Articles / Year598
Total Citations6,740
2022
IF6.921
Articles / Year582
Total Citations9,569

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,020Scopus Q1SCImago Profile
Scopus Coverage:1948-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
2.427

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
4.26

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,996 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations7,160
3-Year Documents1,535
Citable Documents1,024

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)3

Citations in government and international policy documents

Female Author Rate48.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1
OncologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 1.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cancer (abbr: CANCER-AM CANCER SOC, ISSN: 0008-543X) is a peer-reviewed international scholarly journal in the field of Medicine, published by John Wiley and Sons Inc. in United States. The periodical holds a Journal Impact Factor (JIF) of 5.60, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.427 (Q1), an H-index of 359.

The journal enforces rigorous peer evaluation with a publication frequency of Semimonthly, an annual output of approximately 435 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,996 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
John Wiley and Sons Inc.
Publication Language
English
Frequency
Semimonthly
Indexing & Databases
SCIEScopusPubMed
Editorial Address
JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, USA, NJ, 07030

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 08f045d5-b586-4e7c-b0c5-268bed93b15e
Database Updated: 2026-09-28